Description
Opocrin SpA is a prominent group of companies dedicated to the production of biological and chemical Active Pharmaceutical Ingredients (APIs). With a robust reputation as a world leader in the research, production, and commercialisation of pharmaceutical active ingredients and complex molecules, Opocrin specialises in heparins and their derivatives. The company places a strong emphasis on research and development, continually investing in innovation to isolate and develop new life-enhancing products.
Services include:
– Regulatory Services
– APIs (Active Pharmaceutical Ingredients)
Opocrin SpA is committed to providing high-quality services and maintaining its leadership role in the pharmaceutical industry. For more information, visit opocrin.it.
Contact Information
Related Listings

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl

External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel










